{{Rsnum
|rsid=1880242
|Chromosome=7
|position=22719988
|Orientation=plus
|GMAF=0.4784
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 30.1 | 51.3 | 18.6
| HCB | 42.2 | 48.1 | 9.6
| JPT | 66.4 | 29.2 | 4.4
| YRI | 0.7 | 18.4 | 81.0
| ASW | 3.5 | 33.3 | 63.2
| CHB | 42.2 | 48.1 | 9.6
| CHD | 51.9 | 41.7 | 6.5
| GIH | 22.8 | 55.4 | 21.8
| LWK | 4.5 | 33.6 | 61.8
| MEX | 24.6 | 50.9 | 24.6
| MKK | 9.6 | 39.7 | 50.6
| TSI | 18.6 | 46.1 | 35.3
| HapMapRevision=28
}}

[[rs1880242]] is a SNP well upstream of [[IL2]] (Interleukin 2).

{{PMID|19288024}} among 151 patients with obstructive sleep apnea and 75 healthy controls from Southeast China, assoc. of reduced obstructive sleep apnea occurrence in minor allele [[rs1800796]](G) carriers, haplotype [[rs1880242]](T) + [[rs1800796]](G) associated with sig. decreased risk of obstructive sleep apnea than the single [[rs1800796]](G) allele

{{PMID Auto
|PMID=17847004
|Title=Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance.
|OA=1
}}

{{PMID Auto
|PMID=19387461
|Title=Interleukin-6 haplotypes and the response to therapy of chronic hepatitis C virus infection.
|OA=1
}}

{{PMID Auto
|PMID=19401628
|Title=Host genetics, steatosis and insulin resistance among African Americans and Caucasian Americans with hepatitis C virus genotype-1 infection.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}